Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|September 11, 1996

Hologic completes FluoroScan purchase

Bone densitometry firm Hologic last month finalized its purchaseof mini C-arm developer FluoroScan Imaging Systems of Northbrook,IL (SCAN 7/31/96). Hologic, of Waltham, MA, completed the acquisitionthrough a stock swap, in which each share of FluoroScan

Bone densitometry firm Hologic last month finalized its purchase

of mini C-arm developer FluoroScan Imaging Systems of Northbrook,

IL (SCAN 7/31/96). Hologic, of Waltham, MA, completed the acquisition

through a stock swap, in which each share of FluoroScan stock

was exchanged for 0.31069 shares of Hologic stock. The acquisition

is the first step in Hologic's strategy to diversify into new

markets, according to chairman and CEO David Ellenbogen.

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.